Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Decoding primaquine phosphate: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
24 October 2023
This article summarized the latest R&D progress of primaquine phosphate, the Mechanism of Action for primaquine phosphate, and the drug target R&D trends for primaquine phosphate.
Bio Sequence
2 min read
Biological Glossary | What is Aptamer?
24 October 2023
Aptamers are single-stranded DNA or RNA molecules that bind to a specific target molecule.
Drug Insights
4 min read
Deep Scientific Insights on procaine hydrochloride's R&D Progress, Mechanism of Action, and Drug Target
24 October 2023
This article summarized the latest R&D progress of procaine hydrochloride, the Mechanism of Action for procaine hydrochloride, and the drug target R&D trends for procaine hydrochloride.
Valuable Targets
4 min read
Advances in Clinical Research on Acetylcholinesterase Inhibitor
23 October 2023
AChE is responsible for breaking down the neurotransmitter acetylcholine, which is involved in various physiological processes such as muscle contraction, cognition, and memory.
Drug Insights
5 min read
An In-depth Analysis of proxalutamide's R&D Progress and Mechanism of Action on Drug Target
23 October 2023
This article summarized the latest R&D progress of proxalutamide, the Mechanism of Action for proxalutamide, and the drug target R&D trends for proxalutamide.
Latest Hotspot
3 min read
Sanofi's phase 3 clinical trial data for teplizumab published in NEJM, for the treatment of type 1 diabetes
23 October 2023
Recently, Sanofi announced the latest data from the Phase 3 clinical trial named PROTECT for Tzield (teplizumab).
Drug Insights
4 min read
moxifloxacin hydrochloride: Detailed Review of its Transformative R&D Success
23 October 2023
This article summarized the latest R&D progress of moxifloxacin hydrochloride, the Mechanism of Action for moxifloxacin hydrochloride, and the drug target R&D trends for moxifloxacin hydrochloride.
Valuable Targets
8 min read
Analysis on the Research Progress of CGRP Receptor Antagonist
23 October 2023
The CGRP receptor, also known as the calcitonin gene-related peptide receptor, plays a crucial role in the human body.
Drug Insights
5 min read
mupirocin calcium Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
23 October 2023
This article summarized the latest R&D progress of mupirocin calcium, the Mechanism of Action for mupirocin calcium, and the drug target R&D trends for mupirocin calcium.
Latest Hotspot
3 min read
AstraZeneca's C5 complement inhibitor, Eculizumab, has been approved in China for a new indication: the treatment of Neuromyelitis Optica Spectrum Disorder
23 October 2023
Recently, AstraZeneca announced that the National Medical Products Administration (NMPA) of China has approved C5 complement inhibitor Eculizumab for the treatment of adults.
Drug Insights
5 min read
Unleashing the Power of nicardipine hydrochloride: A Comprehensive Review on R&D Breakthroughs
23 October 2023
This article summarized the latest R&D progress of nicardipine hydrochloride, the Mechanism of Action for nicardipine hydrochloride, and the drug target R&D trends for nicardipine hydrochloride.
Valuable Targets
4 min read
Advances in Clinical Research on Amylase Inhibitor
23 October 2023
Amylase is an essential enzyme found in the human body that plays a crucial role in the digestion of carbohydrates.